Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
ITGA5 IS A NOVEL IMMUNOTHERAPEUTIC TARGET AGAINST...
Conference

ITGA5 IS A NOVEL IMMUNOTHERAPEUTIC TARGET AGAINST TREATMENT REFRACTORY MEDULLOBLASTOMA

Authors

Bakhshinyan D; Suk Y; Kuhlman L; Adile A; Ignatchenko V; Gwynne W; Custers S; Macklin A; Venugopal C; Kislinger T

Volume

24

Pagination

pp. 228-228

Publisher

OXFORD UNIV PRESS INC

Publication Date

November 1, 2022

Name of conference

27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

Conference place

Tampa, FL

Conference start date

November 16, 2022

Conference end date

November 20, 2022

Conference proceedings

NEURO-ONCOLOGY

ISSN

1522-8517

Labels

Fields of Research (FoR)